Trial Profile
An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2023
Price :
$35
*
At a glance
- Drugs Brexanolone (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 04 Jun 2023 Status changed from not yet recruiting to recruiting.
- 28 Feb 2022 New trial record